Effects of Sertraline Treatment for Young Children with FXS

Andrew Ligsay; Laura Greiss  Hess; Sarah Fitzpatrick; Kerrie Lemons Chitwood; Jonathan Polussa; Salpi Siyahian; Randi Hagerman

Effects of Sertraline Treatment for Young Children with FXS

Andrew Ligsay, Laura Greiss Hess, Sarah Fitzpatrick, Kerrie Lemons Chitwood, Jonathan Polussa, Salpi Siyahian, Randi Hagerman

Department of Occupational Therapy

Research output: Contribution to conference › Poster

Abstract

Selective serotonin reuptake inhibitors (SSRIs) help treat many of the phenotypic manifestations of fragile X syndrome (FXS) including anxiety, sensory processing challenges, and communication and intellectual deficits. However, the efficacy of SSRIs has not been previously studied in children with FXS under five-years-old. The purpose of this study was to elucidate group differences in behavior and developmental outcome measures for young children with FXS when treated with sertraline compared to placebo.

Original language	American English
State	Published - Oct 2015
Event	American Academy of Pediatrics National Conference and Exhibition - Washington, United States Duration: Oct 24 2015 → Oct 27 2015

Conference

Conference	American Academy of Pediatrics National Conference and Exhibition
Abbreviated title	AAP
Country/Territory	United States
City	Washington
Period	10/24/15 → 10/27/15

Keywords

Fragile X Syndrome
Fragile X
pediatrics

Disciplines

Occupational Therapy

Access to Document

Effects of Sertraline Treatment for Young Children with FXSFinal published version, 357 KBLicense: Unspecified

OpenUrl availability

Full text

Cite this

@conference{c51c4d4175794114966696ab015b2124,

title = "Effects of Sertraline Treatment for Young Children with FXS",

abstract = "Selective serotonin reuptake inhibitors (SSRIs) help treat many of the phenotypic manifestations of fragile X syndrome (FXS) including anxiety, sensory processing challenges, and communication and intellectual deficits. However, the efficacy of SSRIs has not been previously studied in children with FXS under five-years-old. The purpose of this study was to elucidate group differences in behavior and developmental outcome measures for young children with FXS when treated with sertraline compared to placebo.",

keywords = "Fragile X Syndrome, Fragile X, pediatrics",

author = "Andrew Ligsay and Hess, {Laura Greiss} and Sarah Fitzpatrick and {Lemons Chitwood}, Kerrie and Jonathan Polussa and Salpi Siyahian and Randi Hagerman",

year = "2015",

month = oct,

language = "American English",

note = "American Academy of Pediatrics National Conference and Exhibition, AAP ; Conference date: 24-10-2015 Through 27-10-2015",

}

TY - CONF

T1 - Effects of Sertraline Treatment for Young Children with FXS

AU - Ligsay, Andrew

AU - Hess, Laura Greiss

AU - Fitzpatrick, Sarah

AU - Lemons Chitwood, Kerrie

AU - Polussa, Jonathan

AU - Siyahian, Salpi

AU - Hagerman, Randi

PY - 2015/10

Y1 - 2015/10

N2 - Selective serotonin reuptake inhibitors (SSRIs) help treat many of the phenotypic manifestations of fragile X syndrome (FXS) including anxiety, sensory processing challenges, and communication and intellectual deficits. However, the efficacy of SSRIs has not been previously studied in children with FXS under five-years-old. The purpose of this study was to elucidate group differences in behavior and developmental outcome measures for young children with FXS when treated with sertraline compared to placebo.

AB - Selective serotonin reuptake inhibitors (SSRIs) help treat many of the phenotypic manifestations of fragile X syndrome (FXS) including anxiety, sensory processing challenges, and communication and intellectual deficits. However, the efficacy of SSRIs has not been previously studied in children with FXS under five-years-old. The purpose of this study was to elucidate group differences in behavior and developmental outcome measures for young children with FXS when treated with sertraline compared to placebo.

KW - Fragile X Syndrome

KW - Fragile X

KW - pediatrics

UR - https://scholar.dominican.edu/all-faculty/111

M3 - Poster

T2 - American Academy of Pediatrics National Conference and Exhibition

Y2 - 24 October 2015 through 27 October 2015

ER -

Effects of Sertraline Treatment for Young Children with FXS

Abstract

Conference

Keywords

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this